Stock Analysis on Net

Shockwave Medical Inc. (NASDAQ:SWAV)

Balance Sheet: Liabilities and Stockholders’ Equity

The balance sheet provides creditors, investors, and analysts with information on company resources (assets) and its sources of capital (its equity and liabilities). It normally also provides information about the future earnings capacity of a company assets as well as an indication of cash flows that may come from receivables and inventories.

Liabilities represents obligations of a company arising from past events, the settlement of which is expected to result in an outflow of economic benefits from the entity.

Shockwave Medical Inc., consolidated balance sheet: liabilities and stockholders’ equity

US$ in thousands

Microsoft Excel
Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019
Accounts payable 8,868 6,721 3,520 1,466 2,790
Debt, current portion 5,500 3,300 6,667
Employee compensation 49,706 32,885 25,749 10,885 8,139
Asset purchases 7,788 4,600 4,101 2,527
Professional services 6,269 4,044 2,636 1,325 804
Research and development costs 8,122 4,007 4,605 3,057 3,090
Excise, sales, income and other taxes 12,320 4,036 1,232
Sales and marketing 3,495 2,012
Other 3,996 3,791 2,547 2,148 1,744
Accrued liabilities 91,696 55,375 40,870 19,942 13,777
Operating lease liability, current portion 3,641 1,278 1,738 873 774
Current liabilities 104,205 63,374 51,628 25,581 24,008
Operating lease liability, noncurrent portion 35,103 34,928 28,321 7,488 8,125
Convertible debt, noncurrent portion 731,863
Debt, noncurrent portion 24,198 11,630 13,319 7,152
Related party contract liability, noncurrent portion 12,273 12,273 12,273
Deferred tax liabilities 3,609
Long-term income tax liability 1,526
Other liabilities 9,307
Noncurrent liabilities 793,681 71,399 52,224 20,807 15,277
Total liabilities 897,886 134,773 103,852 46,388 39,285
Preferred stock, $0.001 par value per share; no shares issued and outstanding
Common stock, $0.001 par value per share 37 36 35 35 31
Additional paid-in capital 557,882 548,960 494,806 469,283 370,561
Accumulated other comprehensive income (loss) 293 (867) (202) 9 35
Retained earnings (accumulated deficit) 110,465 (36,813) (252,809) (243,673) (177,974)
Stockholders’ equity 668,677 511,316 241,830 225,654 192,653
Total liabilities and stockholders’ equity 1,566,563 646,089 345,682 272,042 231,938

Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31).

Balance sheet item Description The company
Current liabilities Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer. Shockwave Medical Inc. current liabilities increased from 2021 to 2022 and from 2022 to 2023.
Noncurrent liabilities Amount of obligation due after one year or beyond the normal operating cycle, if longer. Shockwave Medical Inc. noncurrent liabilities increased from 2021 to 2022 and from 2022 to 2023.
Total liabilities Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future. Shockwave Medical Inc. total liabilities increased from 2021 to 2022 and from 2022 to 2023.
Stockholders’ equity Total of all stockholders’ equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity stockholders’ equity attributable to the parent excludes the amount of stockholders’ equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity. Shockwave Medical Inc. stockholders’ equity increased from 2021 to 2022 and from 2022 to 2023.